Results 71 to 80 of about 1,027,648 (153)
Reports of side effects associated with the use of drugs 1984
During 1984 the National Drugs Advisory Board received 803 reports, from which 1668 side-effects were recorded. Of these, the largest percentages were as follows: Drugs Affecting the Central Nervous System 50% (including Non-Steroidal Anti-lnfammatory
National Drugs Advisory Board (NDAB)
core
Reports of side effects associated with the use of drugs 1968-1975
The National Drugs Advisory Board received 716 reports from medical and dental practitioners during 1975. From these 1180 side-effects were recorded associated with the use of drugs during the year.
National Drugs Advisory Board (NDAB)
core
Clinical evidence of venoactive drugs in diabetic microvascular complications
Diabetic microvascular complications (DmVCs) and chronic venous disease (CVD) share common risk factors and pathophysiological features. However, they are often assessed and managed as separate conditions. The study objective was to map the available clinical evidence of venoactive drugs (VADs), beyond their demonstrated effects on sign and symptoms of
Gastaldi, Giacomo +9 more
openaire +1 more source
What can we learn from clinical trials of anticonvulsant drugs in epilepsy?
Any physician who intends to utilize the available antiepileptic drugs (AEDs) judiciously, cannot do so without being well versed on their pharmacological properties and the large body of evidence that is continuously accumulating on their relative ...
What Can We Learn From Clinical Trials Of Anticonvulsant Drugs In Epilepsy? +1 more
core +1 more source
Reports of side effects associated with the use of drugs 1977
The National Drugs Advisory Board received 525 Reports in all during 1977. From these 879 Side-Effects were recorded with the use of drugs during the year. There were 18 cases of Drug Interactions- these are listed separately.
National Drugs Advisory Board (NDAB)
core
Drugs for cardiac arrhythmmias, antithrombotic drugs and lipid modulating drugs [PDF]
13.1 Drugs for cardiac arrhythmias\ud 13.1.1 Introduction to cardiac arrhythmias\ud 13.1.2 Cardiac action potentials\ud 13.1.3 Mechanisms of cardiac arrhythmias\ud 13.1.3 Class I\ud 13.1.4 Class II\ud 13.1.5 Class III\ud 12.1.6 Class IV\ud 13.1.7 ...
Doggrell, Sheila
core
Discontinued drugs in 2006: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs
This perspective is the second in a series discussing drugs dropped from development in 2006, with a focus on pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
Ozdemir, Cevdet, AKDIS, Cezmi A.
core +2 more sources
National Drugs Advisory Board. Consolidated annual reports 1991-1994
The past four years have seen events with considerable implications for the Board. The volume of work has continued to grow in the established areas of authorisation and monitoring of human and veterinary medicines, licensing and monitoring of ...
National Drugs Advisory Board (NDAB)
core
Reports of side effects associated with the use of drugs 1987-1988
During 1987 the National Drugs Advisory Board received 1,288 reports concerning patients who experienced adverse reactions associated with the use of medicines. From these reports 2,251 side effects were recorded.
National Drugs Advisory Board (NDAB)
core
Venoactive Drugs, Summary of the Clinical Trials and Guidelines
openaire +2 more sources

